Manhattan Bridge Capital, Inc. (NASDAQ:LOAN – Get Free Report) declared a quarterly dividend on Wednesday, November 27th,Wall Street Journal reports. Shareholders of record on Tuesday, December 31st will be paid a dividend of 0.115 per share by the credit services provider on Wednesday, January 15th. This represents a $0.46 annualized dividend and a yield of 8.58%. The ex-dividend date is Tuesday, December 31st.
Manhattan Bridge Capital has increased its dividend payment by an average of 2.3% annually over the last three years. Manhattan Bridge Capital has a payout ratio of 92.0% meaning its dividend is currently covered by earnings, but may not be in the future if the company’s earnings decline.
Manhattan Bridge Capital Stock Performance
Manhattan Bridge Capital stock traded up $0.08 during midday trading on Wednesday, hitting $5.36. 13,983 shares of the company’s stock were exchanged, compared to its average volume of 20,510. Manhattan Bridge Capital has a 12-month low of $4.50 and a 12-month high of $5.90. The stock has a market cap of $61.32 million, a price-to-earnings ratio of 10.92 and a beta of 0.58. The firm’s 50 day simple moving average is $5.42 and its 200 day simple moving average is $5.29.
Wall Street Analyst Weigh In
Separately, StockNews.com initiated coverage on shares of Manhattan Bridge Capital in a research note on Saturday. They issued a “strong-buy” rating for the company.
Read Our Latest Research Report on LOAN
About Manhattan Bridge Capital
Manhattan Bridge Capital, Inc, a real estate finance company, originates, services, and manages a portfolio of first mortgage loans in the United States. The company offers short-term, secured, and non-banking loans to real estate investors to fund acquisition, renovation, rehabilitation, or development of residential or commercial properties.
Featured Articles
- Five stocks we like better than Manhattan Bridge Capital
- Where to Find Earnings Call Transcripts
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What does consumer price index measure?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Manhattan Bridge Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Manhattan Bridge Capital and related companies with MarketBeat.com's FREE daily email newsletter.